Free Trial

Chinese Stocks To Add to Your Watchlist - May 6th

Charming Medical logo with Services background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's screener highlights five Chinese stocks to watch: Charming Medical (MCTA), Diageo (DEO), UP Fintech (TIGR), Baiya International Group (BIYA), and Regencell Bioscience (RGC).
  • These names were selected for having the highest dollar trading volume recently and span TCM/biotech, brokerage, and consumer alcohol sectors; investors should consider country-specific risks such as regulatory, political, currency exposure and offshore/VIE structures (e.g., Baiya).
  • MarketBeat previews the top five stocks to own by June 1st.

Charming Medical, Diageo, UP Fintech, Baiya International Group, and Regencell Bioscience are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies that are incorporated in or derive a substantial portion of their business from mainland China, representing ownership claims on those firms' assets and earnings. They trade on domestic exchanges (Shanghai, Shenzhen), in Hong Kong and abroad via listings such as A‑shares, H‑shares, red chips and American Depositary Receipts, and carry country-specific risks including regulatory, political and currency exposure that investors should consider. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Charming Medical (MCTA)

We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.

Read Our Latest Research Report on MCTA

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Baiya International Group (BIYA)

We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.

Read Our Latest Research Report on BIYA

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Charming Medical Right Now?

Before you consider Charming Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Charming Medical wasn't on the list.

While Charming Medical currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines